Robert Waibel
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Oncology top 5%
- Peptidase Inhibition and Analysis
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 34
- Radiopharmaceutical Chemistry and Applications 23
-
- Transgenic Plants and Applications 7
- Co-authors
- Roger SchibliAndreas PlückthunRoger AlbertoRolf A. StahelAugust P. SchubigerUlrich AbramP. August SchubigerUwe Zangemeister‐Wittke
- Journals
- International Journal of Cancer (11 papers)Lung Cancer (9 papers)British Journal of Cancer (7 papers)Journal of Thoracic and Cardiovascular Surgery (3 papers)Nuclear Medicine and Biology (3 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Robert Waibel
77 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 110
- Radiology, Nuclear Medicine and Imaging 1.6k
- Oncology 862
- Biotechnology 222
- Immunology 459
- Immunology and Allergy 109
Countries citing papers authored by Robert Waibel
This map shows the geographic impact of Robert Waibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Waibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Waibel more than expected).
Fields of papers citing papers by Robert Waibel
This network shows the impact of papers produced by Robert Waibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Waibel. The network helps show where Robert Waibel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Waibel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 27 | |
| 2 | 2010 | 208 | |
| 3 | 2010 | 25 | |
| 4 | 2008 | 99 | |
| 5 | 2006 | 91 | |
| 6 | 2004 | 48 | |
| 7 | 2004 | 4 | |
| 8 | 2004 | 17 | |
| 9 | 2003 | 157 | |
| 10 | 2001 | 6 | |
| 11 | 2001 | 78 | |
| 12 | Isolation of a panel of human anti-CEA single chain Fv from a large phage display library | 1999 | 0 |
| 13 | High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. | 1999 | 168 |
| 14 | 1993 | 9 | |
| 15 | 1993 | 8 | |
| 16 | 1992 | 28 | |
| 17 | 1992 | 16 | |
| 18 | 1990 | 28 | |
| 19 | 1989 | 34 | |
| 20 | 1975 | 1 |
About Robert Waibel
Robert Waibel is a scholar working on Radiology, Nuclear Medicine and Imaging, Biotechnology, Oncology, Reproductive Medicine and Immunology, having authored 78 papers that have together received 3.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (34 papers), Radiopharmaceutical Chemistry and Applications (23 papers), Glycosylation and Glycoproteins Research (20 papers), Peptidase Inhibition and Analysis (15 papers), Lung Cancer Research Studies (13 papers), Medical Imaging and Pathology Studies (11 papers), Toxin Mechanisms and Immunotoxins (9 papers) and Transgenic Plants and Applications (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.6k citations), Oncology (862 citations), Biotechnology (222 citations), Immunology (459 citations) and Immunology and Allergy (109 citations). Robert Waibel has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Roger Schibli, Andreas Plückthun, Roger Alberto, Rolf A. Stahel, August P. Schubiger, Ulrich Abram, P. August Schubiger, Uwe Zangemeister‐Wittke, Patricia M. Saling and Jörg Willuda. Their work appears in journals such as International Journal of Cancer, Lung Cancer, British Journal of Cancer, Journal of Thoracic and Cardiovascular Surgery and Nuclear Medicine and Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.